FTH

Faeth Therapeutics, Inc. - Common Stock (FTH)

About Faeth Therapeutics, Inc. - Common Stock (FTH)

Faeth Therapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Austin, TX.

Details

Daily high

$29.50

Daily low

$27.37

Price at open

$28.32

52 Week High

$42.14

52 Week Low

$7.45

Market cap

730.5M

Dividend yield

Volume

187,923

Avg. volume

453,919

P/E ratio

-.20

Faeth Therapeutics, Inc. - Common Stock News